NasdaqGS - Delayed Quote USD

Surgery Partners, Inc. (SGRY)

Compare
30.94 -0.49 (-1.56%)
At close: September 4 at 4:00 PM EDT
30.94 0.00 (0.00%)
After hours: September 4 at 4:20 PM EDT
Loading Chart for SGRY
DELL
  • Previous Close 31.43
  • Open 31.30
  • Bid 30.88 x 200
  • Ask 31.04 x 100
  • Day's Range 30.80 - 31.50
  • 52 Week Range 22.05 - 36.92
  • Volume 461,320
  • Avg. Volume 1,148,626
  • Market Cap (intraday) 3.933B
  • Beta (5Y Monthly) 2.76
  • PE Ratio (TTM) --
  • EPS (TTM) -0.26
  • Earnings Date Nov 5, 2024 - Nov 11, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 39.33

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

www.surgerypartners.com

10,500

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SGRY

View More

Performance Overview: SGRY

Trailing total returns as of 9/4/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

SGRY
3.28%
S&P 500
15.73%

1-Year Return

SGRY
17.21%
S&P 500
22.24%

3-Year Return

SGRY
40.00%
S&P 500
21.71%

5-Year Return

SGRY
392.68%
S&P 500
89.94%

Compare To: SGRY

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SGRY

View More

Valuation Measures

Annual
As of 9/4/2024
  • Market Cap

    3.93B

  • Enterprise Value

    7.15B

  • Trailing P/E

    2.69k

  • Forward P/E

    23.64

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.37

  • Price/Book (mrq)

    2.05

  • Enterprise Value/Revenue

    2.50

  • Enterprise Value/EBITDA

    15.24

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -1.17%

  • Return on Assets (ttm)

    3.96%

  • Return on Equity (ttm)

    3.73%

  • Revenue (ttm)

    2.89B

  • Net Income Avi to Common (ttm)

    -33.8M

  • Diluted EPS (ttm)

    -0.26

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    253.7M

  • Total Debt/Equity (mrq)

    95.16%

  • Levered Free Cash Flow (ttm)

    163.25M

Research Analysis: SGRY

View More

Company Insights: SGRY

Research Reports: SGRY

View More

People Also Watch